A Study Of PF-04620110 As A Modified-Release Formulation In Healthy Overweight Or Obese Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The primary purpose of this trial is to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics, of multiple oral doses of PF-04620110 as a modified-release formulation.
Epistemonikos ID: eff56502833bbd711b81c42ce62323bdc8478683
First added on: May 10, 2024